FDA reviewing safety of Sanofi's Lantus insulin

(AP) -- The Food and Drug Administration said Wednesday it is reviewing data on the safety of Lantus, a synthetic insulin made by Sanofi-Aventis SA.

If you want to include this story in your blog, copy and paste this formatted text: